BioSpace News Archive

Relief Therapeutics Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding SA

RELIEF THERAPEUTICS Holding SA announced that at its Extraordinary General Meeting held on Friday, January 28, 2022, the proposed resolutions described in the EGM invitation and detailed below were approved by more than 85 percent of the represented votes.

January 31, 2022
·
3 min read
Business

Immorna Biotherapeutics Expands Its R&D Footprint in RTP, NC and Appoints Key Senior Scientific Leaders

Immorna Biotherapeutics, Inc announces appointment of Drs. NgocDiep Le, Jeffrey Ulmer, Marcin Bugno, Lan Feng, and Mr. Jeffrey Carey to key roles, strengthening its exiting strong leadership team.

January 31, 2022
·
7 min read
Promore Pharma Deregisters Warrants

Promore Pharma announces that the company has had 137 160 warrants deregistered, corresponding to a dilution of 0.2% in programs 1-2 issued to Technomark Group USA LLC and Kentron Biotechnology Pvt Ltd.

January 31, 2022
·
2 min read
Biotech Beach

Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development

Ablexis, LLC and AlivaMab Discovery Services, LLC announced a multi-target licensing agreement between Ablexis and Almirall, S.A., a global biopharmaceutical company focused on skin health, and a research partnership between ADS and Almirall.

January 31, 2022
·
5 min read
Business

Pfizer and Alex Therapeutics announce a Strategic Commercial Partnership to provide evidence-based Digital Therapeutics to patients, starting in Germany

The Stockholm-based Digital Therapeutics company Alex Therapeutics and world leading pharmaceutical company Pfizer have joined forces to provide evidence based, clinically validated and personalized digital therapies to patients.

January 31, 2022
·
5 min read
Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology

Ribbon Biolabs announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from Lansdowne Partners, Helicase Venture as well as several undisclosed investors.

January 31, 2022
·
2 min read
Business

Fennec Pharmaceuticals Announces Management Change - Jan 31, 2022

Fennec Pharmaceuticals Inc. announced that Shubh Goel, the Company’s chief commercial officer, has tendered her resignation and will depart Fennec in late February.

January 31, 2022
·
4 min read
BioMidwest

Ocuphire Presenting New Data and Updates on APX3330 and Nyxol® Clinical Programs at Virtual Investor R&D Day

Ocuphire Pharma, Inc. is hosting a virtual investor R&D Day for the investment community , Monday, January 31 from 10:00am to 12:15pm ET with live Q&A following each session.

January 31, 2022
·
8 min read
Business

Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement

Exopharm Limited has signed a Master Collaborative Services Agreement with the Astellas Institute for Regenerative Medicine.

January 31, 2022
·
5 min read
Biotech Bay

IDEAYA Advances First-in-Class PARG Development Candidate, IDE161, into IND-Enabling Studies and Exercises Option with Cancer Research UK and University of Manchester for Exclusive Worldwide License

IDEAYA Biosciences, Inc. announced initiation of IND-enabling studies for IDE161, a potential first-in-class PARG inhibitor development candidate.

January 31, 2022
·
3 min read